1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
2333.80 38.70 (1.69%)
1.3M
NSE+BSE Volume

NSE 10 Apr, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Lupin gets US FDA nod for ANDA for Dapagliflozin tablets, with a market size of $10.5 bn in 2025 See details

Lupin - LUPIN, 500257 corporate action history

Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Lupin